Efficacy and safety of Angong Niuhuang Pill in the treatment of severe ischemic stroke

The first people's Hospital of Yuhang District, Hangzhou City, Zhejiang Province0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Over 18 years old;
•(2) Acute severe ischemic stroke (NIHSS score > 15);
•(3) Within 24 hours of onset;
•(4) The diagnosis of cerebral infarction was in line with the standards of Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2018;
•(5) The patient or the patient's agent signs the informed consent form.

•(1) Patients with acute cerebral infarction receiving thrombolysis or surgery;
•(2) Patients with end-stage status at admission (GCS score < 5 or mydriasis fixed);
•(3) History of intracranial hemorrhage, intracranial space occupying, brain trauma or other brain diseases;
•(4) Patients with severe liver insufficiency (CTP grade B or above) and severe renal insufficiency (CCR < 30ml / min);
•(5) Patients with primary diseases and malignant tumors of hematopoietic system and immune system;
•(6) Patients who refused or withdrew from the study due to various reasons.

发起方

The first people's Hospital of Yuhang District, Hangzhou City, Zhejiang Province